Early disturbance of microvascular function precedes chemotherapy-induced intestinal injury

Digestive Diseases and Sciences

Volumn 50, Issue 9, 2005, Pages 1729-1733

  Abel, E ^a   Ekman, T ^a   Warnhammar, E ^a   Hultborn, R ^a   Jennische, E ^b   Lange, S ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Chemotherapy; Gastrointestinal toxicity; Intestinal permeability; Microcirculation

Indexed keywords

EDETATE CHROMIUM CR 51; ETOPOFOS; EVANS BLUE; RUBIDIUM CHLORIDE RB 86;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; ENDOLEAK; ENDOTHELIUM LESION; EXTRAVASATION; HISTOPATHOLOGY; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ENDOTHELIUM; ETOPOSIDE; INTESTINAL MUCOSA; INTESTINES; ION CHANNELS; MALE; MICROCIRCULATION; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 23944443827     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2926-9     Document Type: Article

References (22)

1. Khan SA, Wingard JR: Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr 29:31-36, 2001
2. Ziegler TR, Young LS, Benfell K, et al.: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116:821-828, 1992
3. Farrell CL, Bready JV, Rex KL, et al.: Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58:933-939, 1998
4. Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgaci H: The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomised controlled study. Int J Radiat Oncol Biol Phys 54(1):195-202, 2002
5. Ben-Josef E, Han S, Tobi M, et al.: A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. Int J Radiat Oncol Biol Phys 53(5):1160-1164, 2002
6. Lange S: A rat model for an in vivo assault of enterotoxic diarrhoea. FEMS Microbiol 86:49-65, 1975
7. Lange S, Delbro DS, Jennische E, Johansson E, Lönnroth I: Recombinant or plasma-derived antisecretory factor inhibits cholera toxin-induced increase in Evans Blue permeation of rat intestinal capillaries. Dig Dis Sci 43(9):2061-2070, 1998
8. Newman EM, Doroshow JH, Forman SJ, Blume KG: Pharmacokinetics of high-dose etoposide. Clin Pharmacol Ther 43:561-564, 1988
9. Mizushima Y, Konishi K, Morikage T, Yano S: Importance of administration method in high-dose anticancer chemotherapy from toxicological standpoint in rats. Oncology 48:431-437, 1991
10. Bjarnason I, Macpherson A, Hollander D: Intestinal permeability: an overview. Gastroenterology 108:1566-1581, 1995
11. Johansson JE, Soussi B, Bagge U, Ekman T: Disturbance of purine nucleotide metabolism: a possible early key event in the development of intestinal damage induced by chemotherapy. Dig Dis Sci 46(2):257-261, 2001
12. Schultz SG, Dubinsky WP: Sodium absorption, volume control and potassium channels: in tribute to a great biologist. J Membr Biol 184:255-261, 2001
13. Burleigh DE: Involvement of inwardly rectifying K+ channels in secretory responses of human ileal mucosa. J Pharm Pharmacol 55:527-531, 2003
14. Taminiau JA, Gall DG, Hamilton JR: Response of the rat small-intestine epithelium to methotrexate. Gut 21:486-192, 1980
15. Cunningham D, Morgan RJ, Mills PR, Nelson LM, Toner PG, Soukop M, McArdle CS, Russel RI: Functional and structural changes of the human proximal small intestine after cytotoxic therapy. J Clin Pathol 38(3):265-270, 1985
16. Kellner U, Sehested M, Jensen PB, Gieseler F, Rudolph P: Culprit and victim - DNA topoisomerase II. Lancet Oncol 3:235-243, 2002
17. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, Kolesnick R: Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293(5528):293-297, 2001
18. Verburg M, Renes IB, Meijer HP, Taminiau JA, Buller HA, Einerhand AW, Dekker J: Selective sparing of goblet cells and Paneth cells in the intestine of methotrexate-treated rats. Am J Physiol Gastrointest Liver Physiol 279(5):G1037-G1047, 2000
19. Papaconstantinou HT, Xie C, Zhang W, Ansari NH, Hellmich MR, Townsend CM Jr, Ko TC: The role of caspases in methotrexate-induced gastrointestinal toxicity. Surgery 130(5):859-865, 2001
20. Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG: Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci 47(12):2751-2757, 2002
21. Xian CJ, Couper R, Howarth GS, Read LC, Kallincos NC: Increased expression of HGF and c-met in rat small infesting during recovery from methotrexate-induced mucositis. Br J Cancer 82(4):945-952, 2000
22. Keefe DM, Brealey J, Goland GJ, Cummins AG: Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47(5):632-637, 2000